To the content
1 . 2017

The role of drugs for weight reduction in stages management of type 2 diabetes: focus on sibutramine

AbstractAuthors of the article present the epidemiological and pathogenetic aspects of the relationship of type 2 diabetes and obesity, argue for the possibility of including drugs for weight loss in the current recommendations for the treatment of type 2 diabetes with obesity. We consider the case of a real clinical use of sibutramine in combination with metformin, a patient with newly diagnosed type 2 diabetes.

Keywords:diabetes, obesity, sibutramine

Endocrinology: News, Opinions, Training. 2017; (1): 52–59.

DOI: 10.24411/2304-9529-2017-00025



All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»